Is Palantir Stock Going to Crash?
AI and data analytics major Palantir (NASDAQ:PLTR) has become something…
Sell
29
KIDS Quote, Financials, Valuation and Earnings
Last price:
$18.08
Seasonality move
:
1.22%
Day range:
$17.82 - $18.80
52-week range:
$15.28 - $27.30
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.86x
P/B ratio:
1.30x
Volume:
162.2K
Avg. volume:
178.4K
1-year change:
-33.35%
Market cap:
$454.1M
Revenue:
$204.7M
EPS (TTM):
-$1.96
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
KIDS
OrthoPediatrics Corp.
|
$61.3M | -$0.31 | 12.13% | -15.87% | $24.13 |
|
COO
The Cooper Cos., Inc.
|
$1.1B | $1.11 | 6.12% | 98.37% | $91.06 |
|
LUCY
Innovative Eyewear, Inc.
|
$1.2M | -$0.43 | 73.74% | -50.4% | $3.00 |
|
NXGL
NexGel, Inc.
|
$3.2M | -$0.09 | 6.54% | -22.68% | $6.00 |
|
OPK
OPKO Health, Inc.
|
$139.8M | -$0.07 | -23.88% | -900% | $3.56 |
|
STAA
STAAR Surgical Co.
|
$75.5M | $0.15 | 69.01% | 39.51% | $24.08 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
KIDS
OrthoPediatrics Corp.
|
$18.11 | $24.13 | $454.1M | -- | $0.00 | 0% | 1.86x |
|
COO
The Cooper Cos., Inc.
|
$81.29 | $91.06 | $15.9B | 43.38x | $0.01 | 0% | 3.97x |
|
LUCY
Innovative Eyewear, Inc.
|
$1.39 | $3.00 | $7.4M | -- | $0.00 | 0% | 1.89x |
|
NXGL
NexGel, Inc.
|
$1.67 | $6.00 | $13.6M | -- | $0.00 | 0% | 1.09x |
|
OPK
OPKO Health, Inc.
|
$1.32 | $3.56 | $1B | -- | $0.00 | 0% | 1.64x |
|
STAA
STAAR Surgical Co.
|
$19.14 | $24.08 | $944.9M | 49.73x | $0.00 | 0% | 4.12x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
KIDS
OrthoPediatrics Corp.
|
22.39% | -0.306 | 21.68% | 3.39x |
|
COO
The Cooper Cos., Inc.
|
25.25% | -0.042 | 20.32% | 0.89x |
|
LUCY
Innovative Eyewear, Inc.
|
1.01% | 5.916 | 1.04% | 9.17x |
|
NXGL
NexGel, Inc.
|
38.1% | 1.021 | 15.76% | 0.82x |
|
OPK
OPKO Health, Inc.
|
23.25% | 0.394 | 33.19% | 3.02x |
|
STAA
STAAR Surgical Co.
|
9.96% | 0.664 | 2.95% | 4.10x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
KIDS
OrthoPediatrics Corp.
|
$40M | -$4.9M | -10.3% | -12.83% | -7.95% | -$3.4M |
|
COO
The Cooper Cos., Inc.
|
$601M | $140.4M | 3.45% | 4.56% | 13.18% | $149.9M |
|
LUCY
Innovative Eyewear, Inc.
|
$244.8K | -$1.9M | -79.57% | -80% | -287.5% | -$1.5M |
|
NXGL
NexGel, Inc.
|
$1.2M | -$725K | -33.25% | -51.15% | -24.71% | -$793K |
|
OPK
OPKO Health, Inc.
|
$30.4M | -$53.5M | -10.05% | -13.5% | -35.29% | -$37.8M |
|
STAA
STAAR Surgical Co.
|
$76.6M | $44.5M | -23.38% | -25.83% | 46.96% | $1.8M |
OrthoPediatrics Corp. vs. Competitors
-
Which has Higher Returns KIDS or COO?
The Cooper Cos., Inc. has a net margin of -19.22% compared to OrthoPediatrics Corp.'s net margin of 7.94%. OrthoPediatrics Corp.'s return on equity of -12.83% beat The Cooper Cos., Inc.'s return on equity of 4.56%.
Company Gross Margin Earnings Per Share Invested Capital KIDSOrthoPediatrics Corp.65.27% -$0.50 $450.1M COOThe Cooper Cos., Inc.56.42% $0.43 $11B -
What do Analysts Say About KIDS or COO?
OrthoPediatrics Corp. has a consensus price target of $24.13, signalling upside risk potential of 33.21%. On the other hand The Cooper Cos., Inc. has an analysts' consensus of $91.06 which suggests that it could grow by 11.95%. Given that OrthoPediatrics Corp. has higher upside potential than The Cooper Cos., Inc., analysts believe OrthoPediatrics Corp. is more attractive than The Cooper Cos., Inc..
Company Buy Ratings Hold Ratings Sell Ratings KIDSOrthoPediatrics Corp.4 1 0 COOThe Cooper Cos., Inc.6 7 1 -
Is KIDS or COO More Risky?
OrthoPediatrics Corp. has a beta of 1.091, which suggesting that the stock is 9.108% more volatile than S&P 500. In comparison The Cooper Cos., Inc. has a beta of 1.028, suggesting its more volatile than the S&P 500 by 2.836%.
-
Which is a Better Dividend Stock KIDS or COO?
OrthoPediatrics Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Cooper Cos., Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.01 per share. OrthoPediatrics Corp. pays -- of its earnings as a dividend. The Cooper Cos., Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios KIDS or COO?
OrthoPediatrics Corp. quarterly revenues are $61.3M, which are smaller than The Cooper Cos., Inc. quarterly revenues of $1.1B. OrthoPediatrics Corp.'s net income of -$11.8M is lower than The Cooper Cos., Inc.'s net income of $84.6M. Notably, OrthoPediatrics Corp.'s price-to-earnings ratio is -- while The Cooper Cos., Inc.'s PE ratio is 43.38x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OrthoPediatrics Corp. is 1.86x versus 3.97x for The Cooper Cos., Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income KIDSOrthoPediatrics Corp.1.86x -- $61.3M -$11.8M COOThe Cooper Cos., Inc.3.97x 43.38x $1.1B $84.6M
-
Which has Higher Returns KIDS or LUCY?
Innovative Eyewear, Inc. has a net margin of -19.22% compared to OrthoPediatrics Corp.'s net margin of -274.85%. OrthoPediatrics Corp.'s return on equity of -12.83% beat Innovative Eyewear, Inc.'s return on equity of -80%.
Company Gross Margin Earnings Per Share Invested Capital KIDSOrthoPediatrics Corp.65.27% -$0.50 $450.1M LUCYInnovative Eyewear, Inc.36.64% -$0.38 $10.4M -
What do Analysts Say About KIDS or LUCY?
OrthoPediatrics Corp. has a consensus price target of $24.13, signalling upside risk potential of 33.21%. On the other hand Innovative Eyewear, Inc. has an analysts' consensus of $3.00 which suggests that it could grow by 115.83%. Given that Innovative Eyewear, Inc. has higher upside potential than OrthoPediatrics Corp., analysts believe Innovative Eyewear, Inc. is more attractive than OrthoPediatrics Corp..
Company Buy Ratings Hold Ratings Sell Ratings KIDSOrthoPediatrics Corp.4 1 0 LUCYInnovative Eyewear, Inc.0 0 0 -
Is KIDS or LUCY More Risky?
OrthoPediatrics Corp. has a beta of 1.091, which suggesting that the stock is 9.108% more volatile than S&P 500. In comparison Innovative Eyewear, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock KIDS or LUCY?
OrthoPediatrics Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Innovative Eyewear, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OrthoPediatrics Corp. pays -- of its earnings as a dividend. Innovative Eyewear, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios KIDS or LUCY?
OrthoPediatrics Corp. quarterly revenues are $61.3M, which are larger than Innovative Eyewear, Inc. quarterly revenues of $668.1K. OrthoPediatrics Corp.'s net income of -$11.8M is lower than Innovative Eyewear, Inc.'s net income of -$1.8M. Notably, OrthoPediatrics Corp.'s price-to-earnings ratio is -- while Innovative Eyewear, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OrthoPediatrics Corp. is 1.86x versus 1.89x for Innovative Eyewear, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income KIDSOrthoPediatrics Corp.1.86x -- $61.3M -$11.8M LUCYInnovative Eyewear, Inc.1.89x -- $668.1K -$1.8M
-
Which has Higher Returns KIDS or NXGL?
NexGel, Inc. has a net margin of -19.22% compared to OrthoPediatrics Corp.'s net margin of -22.05%. OrthoPediatrics Corp.'s return on equity of -12.83% beat NexGel, Inc.'s return on equity of -51.15%.
Company Gross Margin Earnings Per Share Invested Capital KIDSOrthoPediatrics Corp.65.27% -$0.50 $450.1M NXGLNexGel, Inc.40.93% -$0.08 $8.8M -
What do Analysts Say About KIDS or NXGL?
OrthoPediatrics Corp. has a consensus price target of $24.13, signalling upside risk potential of 33.21%. On the other hand NexGel, Inc. has an analysts' consensus of $6.00 which suggests that it could grow by 259.28%. Given that NexGel, Inc. has higher upside potential than OrthoPediatrics Corp., analysts believe NexGel, Inc. is more attractive than OrthoPediatrics Corp..
Company Buy Ratings Hold Ratings Sell Ratings KIDSOrthoPediatrics Corp.4 1 0 NXGLNexGel, Inc.0 0 0 -
Is KIDS or NXGL More Risky?
OrthoPediatrics Corp. has a beta of 1.091, which suggesting that the stock is 9.108% more volatile than S&P 500. In comparison NexGel, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock KIDS or NXGL?
OrthoPediatrics Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NexGel, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OrthoPediatrics Corp. pays -- of its earnings as a dividend. NexGel, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios KIDS or NXGL?
OrthoPediatrics Corp. quarterly revenues are $61.3M, which are larger than NexGel, Inc. quarterly revenues of $2.9M. OrthoPediatrics Corp.'s net income of -$11.8M is lower than NexGel, Inc.'s net income of -$647K. Notably, OrthoPediatrics Corp.'s price-to-earnings ratio is -- while NexGel, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OrthoPediatrics Corp. is 1.86x versus 1.09x for NexGel, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income KIDSOrthoPediatrics Corp.1.86x -- $61.3M -$11.8M NXGLNexGel, Inc.1.09x -- $2.9M -$647K
-
Which has Higher Returns KIDS or OPK?
OPKO Health, Inc. has a net margin of -19.22% compared to OrthoPediatrics Corp.'s net margin of 14.26%. OrthoPediatrics Corp.'s return on equity of -12.83% beat OPKO Health, Inc.'s return on equity of -13.5%.
Company Gross Margin Earnings Per Share Invested Capital KIDSOrthoPediatrics Corp.65.27% -$0.50 $450.1M OPKOPKO Health, Inc.20.02% $0.03 $1.7B -
What do Analysts Say About KIDS or OPK?
OrthoPediatrics Corp. has a consensus price target of $24.13, signalling upside risk potential of 33.21%. On the other hand OPKO Health, Inc. has an analysts' consensus of $3.56 which suggests that it could grow by 169.57%. Given that OPKO Health, Inc. has higher upside potential than OrthoPediatrics Corp., analysts believe OPKO Health, Inc. is more attractive than OrthoPediatrics Corp..
Company Buy Ratings Hold Ratings Sell Ratings KIDSOrthoPediatrics Corp.4 1 0 OPKOPKO Health, Inc.1 2 0 -
Is KIDS or OPK More Risky?
OrthoPediatrics Corp. has a beta of 1.091, which suggesting that the stock is 9.108% more volatile than S&P 500. In comparison OPKO Health, Inc. has a beta of 1.389, suggesting its more volatile than the S&P 500 by 38.889%.
-
Which is a Better Dividend Stock KIDS or OPK?
OrthoPediatrics Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. OPKO Health, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OrthoPediatrics Corp. pays -- of its earnings as a dividend. OPKO Health, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios KIDS or OPK?
OrthoPediatrics Corp. quarterly revenues are $61.3M, which are smaller than OPKO Health, Inc. quarterly revenues of $151.7M. OrthoPediatrics Corp.'s net income of -$11.8M is lower than OPKO Health, Inc.'s net income of $21.6M. Notably, OrthoPediatrics Corp.'s price-to-earnings ratio is -- while OPKO Health, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OrthoPediatrics Corp. is 1.86x versus 1.64x for OPKO Health, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income KIDSOrthoPediatrics Corp.1.86x -- $61.3M -$11.8M OPKOPKO Health, Inc.1.64x -- $151.7M $21.6M
-
Which has Higher Returns KIDS or STAA?
STAAR Surgical Co. has a net margin of -19.22% compared to OrthoPediatrics Corp.'s net margin of 9.38%. OrthoPediatrics Corp.'s return on equity of -12.83% beat STAAR Surgical Co.'s return on equity of -25.83%.
Company Gross Margin Earnings Per Share Invested Capital KIDSOrthoPediatrics Corp.65.27% -$0.50 $450.1M STAASTAAR Surgical Co.80.89% $0.18 $392.9M -
What do Analysts Say About KIDS or STAA?
OrthoPediatrics Corp. has a consensus price target of $24.13, signalling upside risk potential of 33.21%. On the other hand STAAR Surgical Co. has an analysts' consensus of $24.08 which suggests that it could grow by 25.83%. Given that OrthoPediatrics Corp. has higher upside potential than STAAR Surgical Co., analysts believe OrthoPediatrics Corp. is more attractive than STAAR Surgical Co..
Company Buy Ratings Hold Ratings Sell Ratings KIDSOrthoPediatrics Corp.4 1 0 STAASTAAR Surgical Co.1 9 1 -
Is KIDS or STAA More Risky?
OrthoPediatrics Corp. has a beta of 1.091, which suggesting that the stock is 9.108% more volatile than S&P 500. In comparison STAAR Surgical Co. has a beta of 1.000, suggesting its less volatile than the S&P 500 by 0.048000000000004%.
-
Which is a Better Dividend Stock KIDS or STAA?
OrthoPediatrics Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. STAAR Surgical Co. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OrthoPediatrics Corp. pays -- of its earnings as a dividend. STAAR Surgical Co. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios KIDS or STAA?
OrthoPediatrics Corp. quarterly revenues are $61.3M, which are smaller than STAAR Surgical Co. quarterly revenues of $94.7M. OrthoPediatrics Corp.'s net income of -$11.8M is lower than STAAR Surgical Co.'s net income of $8.9M. Notably, OrthoPediatrics Corp.'s price-to-earnings ratio is -- while STAAR Surgical Co.'s PE ratio is 49.73x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OrthoPediatrics Corp. is 1.86x versus 4.12x for STAAR Surgical Co.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income KIDSOrthoPediatrics Corp.1.86x -- $61.3M -$11.8M STAASTAAR Surgical Co.4.12x 49.73x $94.7M $8.9M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did AMD Stock Go Up?
Since January 9th, shares of chipmaker AMD (NASDAQ:AMD) have been…
Will Data Centers Be In Space?
With demand for data centers seemingly growing by the day,…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
47
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
56
INTC alert for Jan 24
Intel Corp. [INTC] is down 17.01% over the past day.
Buy
64
BNR alert for Jan 24
Burning Rock Biotech Ltd. [BNR] is down 12.81% over the past day.
Sell
19
APGE alert for Jan 24
Apogee Therapeutics, Inc. [APGE] is down 12.28% over the past day.
